FindTrial
Sign In

CLINICAL STUDY ON THE COMBINED EFFECT OF NASAL DROPS WITH MEDICATED OIL (SHUDHA BALA TAILA) AND MEDICATED DECOCTION (BALASAHACHARADI KASHAYA) IN VISWACHI VIS-Ã?-VIS CERVICAL SPONDYLOSIS

AN OPEN LABEL SINGLE ARM STUDY ON THE COMBINED EFFECT OF NASYA WITH SHUDHA BALA TAILA AND BALA SAHACHARADI KASHAYA IN VISWACHI VIS-Ã?-VIS CERVICAL SPONDYLOSIS

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035837
Enrollment
30
Registered
2021-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G542- Cervical root disorders, not elsewhere classified

Interventions

Intervention1: NASYA WITH SHUDHA BALA TAILA : NASYA WITH SHUDHA BALA TAILA WILL BE ADMINISTER FOR 7 DAYS Intervention2: Balasahacharadi kashaya orally for 15 days: Balasahacharadi kashaya 24ml with 2

Sponsors

Dr Priyadarshini H P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects of either Gender Age group between 30 TO 70years Lakshanas of Vishwachi Signs and Symptoms of Cervical Spondylosis Subjects fit for Nasya Karma

Exclusion criteria

Exclusion criteria: Subjects with major systemic diseases that may interfere with the course of treatment Traumatic Infective and Neoplastic conditions of spine Fracture or dislocation of Cervical region

Design outcomes

Primary

MeasureTime frame
To evaluate the combined effect of Nasya with Shudha bala taila and Bala sahacharadi kashaya in viswachi vis-à-vis cervical spondylosis Will evaluate about the reduction in pain and improvements in range of motion of neck and upper limbTimepoint: 16 days—

Secondary

MeasureTime frame
NILTimepoint: Not applicable—

Countries

India

Contacts

Public ContactDr ABDUL KHADER

SRI KALABYRAVESHWARA AYURVEDIC MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTER

abukaya2003@gmail.com9845199790

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026